Platelet activation markers in children with congenital heart disease associated with pulmonary arterial hypertension

被引:17
|
作者
Mese, Timur [1 ]
Guven, Baris [2 ]
Yilmazer, Murat Muhtar [1 ]
Karadeniz, Cem [3 ]
Ozdemir, Rahmi [1 ]
Doksoz, Onder [1 ]
机构
[1] Univ Hlth Sci, Dept Pediat Cardiol, Dr Behcet Uz Childrens Hosp, Fac Med, Izmir, Turkey
[2] Univ Hlth Sci, Dept Pediat Cardiol, Izmir Tepecik Training Hosp, Fac Med, Izmir, Turkey
[3] Katip Celebi Univ, Div Pediat Cardiol, Fac Med, Izmir, Turkey
关键词
congenital heart disease; mean platelet volume; platelet activation; pulmonary hypertension; DISTRIBUTION WIDTH; VOLUME; SURVIVAL; THERAPY; INDEXES; REGISTRY;
D O I
10.1111/chd.12616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Mean platelet volume (MPV), platecrit, and platelet distribution width (PDW) are markers of platelet activation. Previous studies have found that platelet activation occurs in patients with pulmonary arterial hypertension. Platelet indices including MPV, PDW, and platecrit have not been studied in children with congenital heart disease associated pulmonary arterial hypertension (APAH-CHD) who survived and those who died. Objective: The objective of this study to investigate the value of platelet indices with clinical and hemodynamic indicators predicting the disease severity and survival in children with APAH-CHD. Methods: This was a nested case-control study. MPV, platecrit, and PDW levels measured in 37 patients with APAH-CHD and 43 healthy subjects at the beginning of the study. Right heart catheterization was performed in all 37 patients. Clinical and hemodynamic data were collected. All patients were followed from the date of laboratory testing. The study was conducted between March 2012-July 2015. The comparison of clinical, hemodynamic data and platelet indices were made between patients with APAH-CHD who died than APAH-CHD patients who survived. Results: Of 37 patients, after a mean follow-up duration of 67.90647.90 months, 11 patients died. MPV (12.10 femoliter [fL; 8.20-12.50] vs 8.70 fL [6.40-9.70], P5.007), PDW (16.88 +/- 1.09% vs 15.75 +/- 1.58%, P = .04) and platecrit (0.28 +/- 0.31 vs 0.22 +/- 0.27, P = .01) were significantly higher in the patients with APAH-CHD who died than those who survived. Pearson's correlation analysis showed that MPV correlated with mean pulmonary artery pressure (r = 0.332, P = .04) and correlated negatively with six-minute walking distance (r = -0.600. P = .00). PDW and platecrit correlated positively with mean pulmonary artery pressure (r = 0.373, P = .02; r = 0.389, P = .01, respectively). Conclusion: Our results showed that MPV, platecrit and PDW were increased in children with APAH-CHD. They might give clue about disease severity.
引用
收藏
页码:506 / 511
页数:6
相关论文
共 50 条
  • [31] Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension
    Pfarr, Nicole
    Fischer, Christine
    Ehlken, Nicola
    Becker-Gruenig, Tabea
    Lopez-Gonzalez, Vanesa
    Gorenflo, Matthias
    Hager, Alfred
    Hinderhofer, Katrin
    Miera, Oliver
    Nagel, Christian
    Schranz, Dietmar
    Gruenig, Ekkehard
    [J]. RESPIRATORY RESEARCH, 2013, 14
  • [32] Hemodynamic and genetic analysis in children with idiopathic/heritable and congenital heart disease associated pulmonary arterial hypertension
    Pfarr, N.
    Fischer, C.
    Ehlken, N.
    Becker-Gruenig, T.
    Miera, O.
    Gorenflo, M.
    Hager, A.
    Nagel, C.
    Schranz, D.
    Gruenig, E.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 1030 - 1031
  • [33] Pulmonary arterial hypertension associated with congenital heart disease in children and adults: knowing the present to imagine the future
    Playan Escribano, J.
    Garrido-Lestache, E.
    Segura De la Cal, T.
    Alvarez Fuente, M.
    Lopez-Meseguer, M.
    Labrandero, C.
    Perez Penate, G. M.
    Mendoza Soto, A.
    Domingo Morera, J. A.
    Caicedo Cuenca, L. M.
    Garcia Hernandez, F. J.
    Sabate Rotes, A.
    Lopez Reyes, R.
    Escribano Subias, P.
    Del Cerro Marin, M. J.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1907 - 1907
  • [34] Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
    Lopes, Antonio
    Alnajashi, Khalid
    [J]. ANNALS OF THORACIC MEDICINE, 2014, 9 (05) : 21 - 25
  • [35] Clinical classification in pediatric pulmonary arterial hypertension associated with congenital heart disease
    Zijlstra, Willemijn M. H.
    Douwes, Johannes M.
    Ploegstra, Mark-Jan
    Krishnan, Usha
    Roofthooft, Marcus T. R.
    Hillege, Hans L.
    Ivy, D. Dunbar
    Rosenzweig, Erika B.
    Berger, Rolf M. F.
    [J]. PULMONARY CIRCULATION, 2016, 6 (03) : 302 - 312
  • [36] Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease
    Becker-Gruenig, Tabea
    Klose, Hans
    Ehlken, Nicola
    Lichtblau, Mona
    Nagel, Christian
    Fischer, Christine
    Gorenflo, Matthias
    Tiede, Henning
    Schranz, Dietmar
    Hager, Alfred
    Kaemmerer, Harald
    Miera, Oliver
    Ulrich, Silvia
    Speich, Rudolf
    Uiker, Soeren
    Gruenig, Ekkehard
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 375 - 381
  • [37] Clinical Classification In Pediatric Pulmonary Arterial Hypertension Associated With Congenital Heart Disease
    Zijlstra, W. M. H.
    Douwes, J. M.
    Ploegstra, M. -J.
    Krishnan, U.
    Roofthooft, M. T.
    Hillege, H. L.
    Ivy, D.
    Rosenzweig, E. B.
    Berger, R. M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [38] Non-congenital heart disease associated pediatric pulmonary arterial hypertension
    Ivy, D. D.
    Feinstein, J. A.
    Humpl, T.
    Rosenzweig, E. B.
    [J]. PROGRESS IN PEDIATRIC CARDIOLOGY, 2009, 27 (1-2) : 13 - 23
  • [39] Pulmonary-arterial Hypertension (PAH) associated with congenital Heart Disease (CHD)
    Campean, I. -A.
    [J]. JOURNAL FUR KARDIOLOGIE, 2015, 22 (11-12): : 288 - 289
  • [40] The Treatment of Congenital Heart Disease Associated Pulmonary Arterial Hypertension (PAH) with Sildenafil
    Crackett, R. M.
    Foggo, B. A.
    Day, M. B.
    Small, T.
    Mackay, L. S.
    Fisher, A. J.
    Lordan, J. L.
    MacGowan, G.
    Corris, P. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179